Outcome of Coronary High Angulated Bifurcation Lesions Treated With Kissing Ballooning or Sequential Ballooning Techniques (MV:main branch)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02137486|
Recruitment Status : Recruiting
First Posted : May 13, 2014
Last Update Posted : May 2, 2017
Coronary artery bifurcation lesions prone to occur with the worsening of atherosclerosis. Their structural properties make angioplasty technique to increase the difficulty of implementation, but also increased the risks of the in-stent thrombosis and restenosis. Standard treatment of coronary bifurcation lesions remains controversial manner, especially when the side branch (SB) was large combined with high angulated bifurcation lesions. Complex procedures and certain types of lesions are associated with poor prognosis. There is no standard treatment for such lesions even with the development of drug-eluting stents solve partial problems. The investigators reviewed patients who received coronary intervention between 2009-2012 years and met the inclusion criteria, and then analyzed the prognostic relevance of these cases the use of different treatment modalities.
We introduced a retrospective analysis for high angulated bifurcation lesions with intermediate to high complexity(SYNTAX>22) treated with either DES or BMS.
Primary endpoint: cardiovascular mortality, TLR, MACE. secondary endpoint: procedure time, fluoroscopy time, procedure success, angiographic success.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||214 participants|
|Official Title:||Outcome of Coronary High Angulated Bifurcation Lesions Treated With Kissing Ballooning or Sequential Ballooning Techniques|
|Study Start Date :||April 2015|
|Actual Primary Completion Date :||June 2016|
|Estimated Study Completion Date :||October 2017|
- MACE(%) [ Time Frame: 24 months ]as medical chart record.
- PRU [ Time Frame: 24 months ]as medical chart record.
- cardiovascular mortality(%) [ Time Frame: 24 months ]as medical chart record.
- angiographic success(%) [ Time Frame: 24 months. ]as medical chart record.
- target vessel revascularization rate(%) [ Time Frame: 24 months. ]as medical chart record.
- fluoroscopy time(minutes) [ Time Frame: 24 months. ]as medical chart record.
- procedure time(minutes) [ Time Frame: 24 months. ]as medical chart record.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02137486
|Contact: Chen Yueh Chung, chief doctor||886227093600 ext firstname.lastname@example.org|
|Taipei city hospital||Recruiting|
|Taipei, Taiwan, 52005|
|Contact: Chen Yueh Chung 886227093600 ext 3741 email@example.com|